Oncotelic Therapeutics Statistics
Total Valuation
OTLC has a market cap or net worth of $14.39 million. The enterprise value is $27.20 million.
Market Cap | 14.39M |
Enterprise Value | 27.20M |
Important Dates
The last earnings date was Thursday, April 13, 2023.
Earnings Date | Apr 13, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
OTLC has 399.68 million shares outstanding. The number of shares has increased by 1.87% in one year.
Shares Outstanding | 399.68M |
Shares Change (YoY) | +1.87% |
Shares Change (QoQ) | +0.35% |
Owned by Insiders (%) | 54.83% |
Owned by Institutions (%) | n/a |
Float | 180.54M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 4.03 |
PS Ratio | 205.55 |
Forward PS | n/a |
PB Ratio | 1.19 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 388.50 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02, with a Debt / Equity ratio of 1.07.
Current Ratio | 0.02 |
Quick Ratio | 0.01 |
Debt / Equity | 1.07 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -0.63 |
Financial Efficiency
Return on equity (ROE) is -71.22% and return on invested capital (ROIC) is -26.60%.
Return on Equity (ROE) | -71.22% |
Return on Assets (ROA) | -28.78% |
Return on Capital (ROIC) | -26.60% |
Revenue Per Employee | $3,182 |
Profits Per Employee | -$392,695 |
Employee Count | 22 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | -5.39M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.50% in the last 52 weeks. The beta is 0.06, so OTLC's price volatility has been lower than the market average.
Beta (1Y) | 0.06 |
52-Week Price Change | +0.50% |
50-Day Moving Average | 0.04 |
200-Day Moving Average | 0.03 |
Relative Strength Index (RSI) | 51.28 |
Average Volume (30 Days) | 76,040 |
Short Selling Information
The latest short interest is 662,753, so 0.17% of the outstanding shares have been sold short.
Short Interest | 662,753 |
Short Previous Month | 812,771 |
Short % of Shares Out | 0.17% |
Short % of Float | 0.37% |
Short Ratio (days to cover) | 8.04 |
Income Statement
In the last 12 months, OTLC had revenue of $70,000 and -$8.64 million in losses. Loss per share was -$0.02.
Revenue | 70,000 |
Gross Profit | 70,000 |
Operating Income | -6.69M |
Pretax Income | -8.21M |
Net Income | -8.64M |
EBITDA | -492,622 |
EBIT | -659,056 |
Loss Per Share | -$0.02 |
Balance Sheet
The company has $190,405 in cash and $13.00 million in debt, giving a net cash position of -$12.81 million or -$0.03 per share.
Cash & Cash Equivalents | 190,405 |
Total Debt | 13.00M |
Net Cash | -12.81M |
Net Cash Per Share | -$0.03 |
Equity / Book Value | 12.13M |
Book Value Per Share | 0.03 |
Working Capital | -16.23M |
Cash Flow
Operating Cash Flow | -1.32M |
Capital Expenditures | n/a |
Free Cash Flow | -1.32M |
FCF Per Share | -$0.00 |
Margins
Gross margin is 100.00%, with operating and profit margins of -9,550.00% and -12,341.86%.
Gross Margin | 100.00% |
Operating Margin | -9,550.00% |
Pretax Margin | -11,722.95% |
Profit Margin | -12,341.86% |
EBITDA Margin | -703.75% |
EBIT Margin | -941.51% |
FCF Margin | -1,887.21% |
Dividends & Yields
OTLC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.87% |
Shareholder Yield | -1.87% |
Earnings Yield | -60.04% |
FCF Yield | -9.18% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 28, 2012. It was a reverse split with a ratio of 1:12.
Last Split Date | Dec 28, 2012 |
Split Type | Reverse |
Split Ratio | 1:12 |
Scores
OTLC has an Altman Z-Score of -1.81 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.81 |
Piotroski F-Score | 1 |